The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Zhendi Wang,3 Fang Zeng,1,2 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Hubei Province Clinical Research Center for Precision Medicine for...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-12-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/the-effects-of-oral-sodium-bicarbonate-on-renal-function-and-cardiovas-peer-reviewed-fulltext-article-TCRM |
_version_ | 1818426133595553792 |
---|---|
author | Cheng F Li Q Wang J Wang Z Zeng F Zhang Y |
author_facet | Cheng F Li Q Wang J Wang Z Zeng F Zhang Y |
author_sort | Cheng F |
collection | DOAJ |
description | Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Zhendi Wang,3 Fang Zeng,1,2 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, People’s Republic of China; 3Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence: Fang Zeng; Yu ZhangDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaEmail fancyzeng@126.com; zhangwkp@163.comObjective: Oral sodium bicarbonate is often used to correct acid-base disturbance in patients with chronic kidney disease (CKD). However, there is little evidence on patient-level benign outcomes to support the practice.Methods: We conducted a systematic review and meta-analysis to examine the efficacy and safety of oral sodium bicarbonate in CKD patients. A total of 1853 patients with chronic metabolic acidosis or those with low-normal serum bicarbonate (22– 24 mEq/L) were performed to compare the efficacy and safety of oral sodium bicarbonate in patients with CKD.Results: There was a significant increase in serum bicarbonate level (MD 2.37 mEq/L; 95% CI, 1.03 to 3.72) and slowed the decline in estimated glomerular filtration rate (eGFR) (MD − 4.44 mL/min per 1.73 m2, 95% CI, − 4.92 to − 3.96) compared with the control groups. The sodium bicarbonate lowered T50-time, an indicator of vascular calcification (MD − 20.74 min; 95% CI, − 49.55 to 8.08); however, there was no significant difference between the two groups. In addition, oral sodium bicarbonate dramatically reduced systolic blood pressure (MD − 2.97 mmHg; 95% CI, − 5.04 to − 0.90) and diastolic blood pressure (MD − 1.26 mmHg; 95% CI, − 2.33 to − 0.19). There were no statistically significant body weight, urine pH and mean mid-arm muscle circumference.Conclusion: Treatment of metabolic acidosis with sodium bicarbonate may slow the decline rate of kidney function and potentially significantly improve vascular endothelial function in patients with CKD.Prospero Registration Number: CRD42020207185.Keywords: chronic kidney disease, metabolic acidosis, sodium bicarbonate, kidney function, cardiovascular risk |
first_indexed | 2024-12-14T14:24:59Z |
format | Article |
id | doaj.art-d0b54a9f6b10404ea9ec7723d9fd9051 |
institution | Directory Open Access Journal |
issn | 1178-203X |
language | English |
last_indexed | 2024-12-14T14:24:59Z |
publishDate | 2021-12-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Therapeutics and Clinical Risk Management |
spelling | doaj.art-d0b54a9f6b10404ea9ec7723d9fd90512022-12-21T22:57:59ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2021-12-01Volume 171321133171262The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-AnalysisCheng FLi QWang JWang ZZeng FZhang YFang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Zhendi Wang,3 Fang Zeng,1,2 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, People’s Republic of China; 3Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence: Fang Zeng; Yu ZhangDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaEmail fancyzeng@126.com; zhangwkp@163.comObjective: Oral sodium bicarbonate is often used to correct acid-base disturbance in patients with chronic kidney disease (CKD). However, there is little evidence on patient-level benign outcomes to support the practice.Methods: We conducted a systematic review and meta-analysis to examine the efficacy and safety of oral sodium bicarbonate in CKD patients. A total of 1853 patients with chronic metabolic acidosis or those with low-normal serum bicarbonate (22– 24 mEq/L) were performed to compare the efficacy and safety of oral sodium bicarbonate in patients with CKD.Results: There was a significant increase in serum bicarbonate level (MD 2.37 mEq/L; 95% CI, 1.03 to 3.72) and slowed the decline in estimated glomerular filtration rate (eGFR) (MD − 4.44 mL/min per 1.73 m2, 95% CI, − 4.92 to − 3.96) compared with the control groups. The sodium bicarbonate lowered T50-time, an indicator of vascular calcification (MD − 20.74 min; 95% CI, − 49.55 to 8.08); however, there was no significant difference between the two groups. In addition, oral sodium bicarbonate dramatically reduced systolic blood pressure (MD − 2.97 mmHg; 95% CI, − 5.04 to − 0.90) and diastolic blood pressure (MD − 1.26 mmHg; 95% CI, − 2.33 to − 0.19). There were no statistically significant body weight, urine pH and mean mid-arm muscle circumference.Conclusion: Treatment of metabolic acidosis with sodium bicarbonate may slow the decline rate of kidney function and potentially significantly improve vascular endothelial function in patients with CKD.Prospero Registration Number: CRD42020207185.Keywords: chronic kidney disease, metabolic acidosis, sodium bicarbonate, kidney function, cardiovascular riskhttps://www.dovepress.com/the-effects-of-oral-sodium-bicarbonate-on-renal-function-and-cardiovas-peer-reviewed-fulltext-article-TCRMchronic kidney diseasemetabolic acidosissodium bicarbonatekidney functioncardiovascular risk |
spellingShingle | Cheng F Li Q Wang J Wang Z Zeng F Zhang Y The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis Therapeutics and Clinical Risk Management chronic kidney disease metabolic acidosis sodium bicarbonate kidney function cardiovascular risk |
title | The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis |
title_full | The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis |
title_fullStr | The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis |
title_full_unstemmed | The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis |
title_short | The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis |
title_sort | effects of oral sodium bicarbonate on renal function and cardiovascular risk in patients with chronic kidney disease a systematic review and meta analysis |
topic | chronic kidney disease metabolic acidosis sodium bicarbonate kidney function cardiovascular risk |
url | https://www.dovepress.com/the-effects-of-oral-sodium-bicarbonate-on-renal-function-and-cardiovas-peer-reviewed-fulltext-article-TCRM |
work_keys_str_mv | AT chengf theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT liq theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT wangj theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT wangz theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT zengf theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT zhangy theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT chengf effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT liq effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT wangj effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT wangz effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT zengf effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis AT zhangy effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis |